Viking Therapeutics (VKTX) and Zealand Pharma report a successful phase 2 for weight loss drugs. Maurits Pot discusses the emergence of strong weight loss drug players. He talks about the outlook for weight loss companies. Tune in to find out more about the stock market today.
The Watch List
05 Mar 2024
SHARE